These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21382312)

  • 1. Patients and clinicians report higher-than-average satisfaction with psychiatric genotyping for depressed inpatients.
    Kung S; Allen JD
    J Clin Psychiatry; 2011 Feb; 72(2):262-3. PubMed ID: 21382312
    [No Abstract]   [Full Text] [Related]  

  • 2. New technologies: the good, the bad, and the ugly.
    Hollander E
    CNS Spectr; 2009 Jan; 14(1):8. PubMed ID: 19169182
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study.
    Honeycutt DC; Blom TJ; Ramsey LB; Strawn JR; Bruns KM; Welge JA; Patino LR; Singh MK; DelBello MP
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):42-51. PubMed ID: 38377518
    [No Abstract]   [Full Text] [Related]  

  • 4. Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Practical issues related to medication selection.
    Smoller JW
    CNS Spectr; 2006 Mar; 11(3 Suppl 3):5-7. PubMed ID: 17760223
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients.
    Serretti A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Sens-Espel R; Bollen J; Zohar J; Berlo J; Lienard P; De Ronchi D; Mendlewicz J; Souery D
    Int Clin Psychopharmacol; 2009 Sep; 24(5):250-6. PubMed ID: 19593158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A severely depressed woman with an unusual response to antidepressants].
    Sundfjord N; Tran GT; Haver B
    Tidsskr Nor Laegeforen; 2018 Apr; 138(7):. PubMed ID: 29663782
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenomics of antidepressant treatment effects.
    Licinio J; Wong ML
    Dialogues Clin Neurosci; 2011; 13(1):63-71. PubMed ID: 21485747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.
    Bousman CA; Stevenson JM; Ramsey LB; Sangkuhl K; Hicks JK; Strawn JR; Singh AB; Ruaño G; Mueller DJ; Tsermpini EE; Brown JT; Bell GC; Leeder JS; Gaedigk A; Scott SA; Klein TE; Caudle KE; Bishop JR
    Clin Pharmacol Ther; 2023 Jul; 114(1):51-68. PubMed ID: 37032427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings?
    Taranu A; Colle R; Gressier F; El Asmar K; Becquemont L; Corruble E; Verstuyft C
    Pharmacogenomics; 2017 May; 18(7):639-650. PubMed ID: 28480819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics to prevent maniac affective switching with treatment for bipolar disorder: CYP2D6.
    Sánchez-Martín A; Sánchez-Iglesias S; García-Berrocal B; Lorenzo C; Gaedigk A; Isidoro-García M
    Pharmacogenomics; 2016 Aug; 17(12):1291-3. PubMed ID: 27469479
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.
    Hall-Flavin DK; Winner JG; Allen JD; Carhart JM; Proctor B; Snyder KA; Drews MS; Eisterhold LL; Geske J; Mrazek DA
    Pharmacogenet Genomics; 2013 Oct; 23(10):535-48. PubMed ID: 24018772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
    Ng C; Sarris J; Singh A; Bousman C; Byron K; Peh LH; Smith DJ; Tan CH; Schweitzer I
    Hum Psychopharmacol; 2013 Sep; 28(5):516-22. PubMed ID: 24014145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder.
    Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
    Eur Arch Psychiatry Clin Neurosci; 2013 Aug; 263(5):385-91. PubMed ID: 23081704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
    Quaranta S; Dupouey J; Colle R; Verstuyft C
    Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic studies of drug response and side effects in the STAR*D study, part 2.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacogenetics and interactions of antidepressants in the treatment of co-morbid illness.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
    Psychiatr Danub; 2009 Sep; 21(3):399-400. PubMed ID: 19794364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do we need pharmacogenetics to personalize antidepressant therapy?
    Lanni C; Racchi M; Govoni S
    Cell Mol Life Sci; 2013 Sep; 70(18):3327-40. PubMed ID: 23272319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genotyping of CYP2D6 and CYP2C19].
    Slanar O; Drazd'áková M; Babiárová K; Pechandová K; Buzková H; Perlík F; Zima T
    Cas Lek Cesk; 2007; 146(9):708-11. PubMed ID: 17966194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
    Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH
    Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine pharmacogenetics: a comprehensive review.
    Suwała J; Machowska M; Wiela-Hojeńska A
    Pharmacogenomics; 2019 Jul; 20(11):829-845. PubMed ID: 31368838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.